· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
INNOVATIVE CONSULTING INC — INNOVATIVE CONSULTING 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250801103818NAL0003723987027
INNOVATIVE CONSULTING INC
Form 5500-SF
FILING_RECEIVED
INNOVATIVE CONSULTING 401(K) PLAN
401(k) retirement plan
Active participants
22
Accounts w/ balance
21
Plan assets (EOY)
$347K
Net assets (EOY)
$347K
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
INNOVATIVE CONSULTING INC
.
Find decision makers
Plan sponsor
Name
INNOVATIVE CONSULTING INC
EIN
46-5601087
Address
5613 NW 147TH PL · PORTLAND, OR · 97229
Phone
(503) 360-3987
Industry
Manufacturing
see all
Plan administrator
Name
GUIDELINE RK, LLC
EIN
30-1418950
City
BURLINGAME, CA
Phone
(888) 228-3491
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-08-01
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2S · Automatic enrollment
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Manufacturing plans
PHAST PHARMACY
PHAST PHARMACY 401(K) PLAN
$346K · 14 participants
MOLECULAR PARTNERS INC
MOLECULAR PARTNERS INC 401(K)
$345K · 2 participants
CLINICAL PHARMACOLOGY SERVICES
CLINICAL PHARMACOLOGY SERVICES 401(K) PROFIT SHARING PLAN & TRUST
$350K · 5 participants
RINATI SKIN, LLC
RINATI SKIN, LLC 401(K) P/S PLAN
$343K · 16 participants
EVOQ THERAPEUTICS, INC.
EVOQ THERAPEUTICS, INC. 401(K) PLAN
$343K · 6 participants
100
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
OLYMPIA PHARMACEUTICALS
OLYMPIA PHARMACEUTICALS 401(K) PLAN
$343K · 203 participants
Large plans in Oregon
STANDARD INSURANCE COMPANY
SEPARATE ACCOUNT A
$12.5B
PRINCIPAL GLOBAL INVESTORS TRUST COMPANY
DIVERSIFIED INTERNATIONAL EQUITY FUND
$12.1B
PRINCIPAL GLOBAL INVESTORS TRUST COMPANY
MORLEY STABLE VALUE FUND
$11.1B
PRINCIPAL GLOBAL INVESTORS TRUST COMPANY
PRINCIPAL LIFETIME HYBRID 2030 CIT
$10.9B
PRINCIPAL GLOBAL INVESTORS TRUST COMPANY
PRINCIPAL LIFETIME HYBRID 2040 CIT
$10.4B
PRINCIPAL GLOBAL INVESTORS TRUST COMPANY
PRINCIPAL LIFETIME HYBRID 2035 CIT
$8.6B
